# A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

> **NCT00942435** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 156 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** YM150
- **PROCEDURE:** mechanical prophylaxis

## Key facts

- **NCT ID:** NCT00942435
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2010-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942435, "A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00942435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*